Karen M McDowell1, Alan H Jobe2,3, Matthew Fenchel1,4, William D Hardie1, Tate Gisslen2,3, Lisa R Young1, Claire A Chougnet5, Stephanie D Davis6, Suhas G Kallapur2,3. 1. 1 Division of Pulmonary Medicine. 2. 2 Division of Neonatology. 3. 3 Division of Pulmonary Biology. 4. 4 Division of Epidemiology and Biostatistics, and. 5. 5 Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center, and the University of Cincinnati College of Medicine, Cincinnati, Ohio; and. 6. 6 Section of Pediatric Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana.
Abstract
RATIONALE: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. OBJECTIVES: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. METHODS: Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. MEASUREMENTS AND MAIN RESULTS: A total of 25% of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). CONCLUSIONS: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girl infants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.
RATIONALE: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. OBJECTIVES: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. METHODS:Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. MEASUREMENTS AND MAIN RESULTS: A total of 25% of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). CONCLUSIONS: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girlinfants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.
Authors: Luciana Friedrich; Paulo M C Pitrez; Renato T Stein; Marcelo Goldani; Robert Tepper; Marcus H Jones Journal: Am J Respir Crit Care Med Date: 2007-09-20 Impact factor: 21.405
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Markus Gantert; Reint K Jellema; Heike Heineman; Julia Gantert; Jennifer J P Collins; Matthias Seehase; Verena A C Lambermont; Alexander Keck; Yves Garnier; Luc J I Zimmermann; Mahmed Kadyrov; A W Danilo Gavilanes; Boris W Kramer Journal: Neonatology Date: 2012-05-17 Impact factor: 4.035
Authors: Bo L K Chawes; Jakob Stokholm; Klaus Bønnelykke; Susanne Brix; Hans Bisgaard Journal: J Allergy Clin Immunol Date: 2015-01-08 Impact factor: 10.793
Authors: Timothy P Stevens; Neil N Finer; Waldemar A Carlo; Peter G Szilagyi; Dale L Phelps; Michele C Walsh; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Jamie E Newman; Abhik Das; Barbara T Do; Kurt Schibler; Wade Rich; Nancy S Newman; Richard A Ehrenkranz; Myriam Peralta-Carcelen; Betty R Vohr; Deanne E Wilson-Costello; Kimberly Yolton; Roy J Heyne; Patricia W Evans; Yvonne E Vaucher; Ira Adams-Chapman; Elisabeth C McGowan; Anna Bodnar; Athina Pappas; Susan R Hintz; Michael J Acarregui; Janell Fuller; Ricki F Goldstein; Charles R Bauer; T Michael O'Shea; Gary J Myers; Rosemary D Higgins Journal: J Pediatr Date: 2014-04-13 Impact factor: 4.406
Authors: Jasper V Been; Marlies J Lugtenberg; Eline Smets; Constant P van Schayck; Boris W Kramer; Monique Mommers; Aziz Sheikh Journal: PLoS Med Date: 2014-01-28 Impact factor: 11.069
Authors: Carolyn Black; Joan E Gerriets; Justin H Fontaine; Richart W Harper; Nicholas J Kenyon; Fern Tablin; Edward S Schelegle; Lisa A Miller Journal: Am J Respir Cell Mol Biol Date: 2017-05 Impact factor: 6.914
Authors: Andrea Toth; Shelby Steinmeyer; Paranthaman Kannan; Jerilyn Gray; Courtney M Jackson; Shibabrata Mukherjee; Martin Demmert; Joshua R Sheak; Daniel Benson; Joseph Kitzmiller; Joseph A Wayman; Pietro Presicce; Christopher Cates; Rhea Rubin; Kashish Chetal; Yina Du; Yifei Miao; Mingxia Gu; Minzhe Guo; Vladimir V Kalinichenko; Suhas G Kallapur; Emily R Miraldi; Yan Xu; Daniel Swarr; Ian Lewkowich; Nathan Salomonis; Lisa Miller; Jennifer S Sucre; Jeffrey A Whitsett; Claire A Chougnet; Alan H Jobe; Hitesh Deshmukh; William J Zacharias Journal: Sci Transl Med Date: 2022-03-30 Impact factor: 19.319
Authors: Courtney M Jackson; Shibabrata Mukherjee; Adrienne N Wilburn; Chris Cates; Ian P Lewkowich; Hitesh Deshmukh; William J Zacharias; Claire A Chougnet Journal: Front Immunol Date: 2020-06-19 Impact factor: 7.561
Authors: Anne Marie Singh; Michael G Sherenian; Kwang-Youn Kim; Kristin A Erickson; Amy Yang; Karen Mestan; Linda M Ernst; Rajesh Kumar Journal: Allergy Asthma Clin Immunol Date: 2018-11-19 Impact factor: 3.406
Authors: Clement L Ren; Rui Feng; Stephanie D Davis; Eric Eichenwald; Alan Jobe; Paul E Moore; Howard B Panitch; Jack K Sharp; Jeff Kisling; Charles Clem; James S Kemp Journal: Ann Am Thorac Soc Date: 2018-11
Authors: Kriti Puri; Diana H Taft; Namasivayam Ambalavanan; Kurt R Schibler; Ardythe L Morrow; Suhas G Kallapur Journal: PLoS One Date: 2016-09-22 Impact factor: 3.240
Authors: Margaret E Kuper-Sassé; Peter M MacFarlane; Catherine A Mayer; Richard J Martin; Y S Prakash; Christina M Pabelick; Thomas M Raffay Journal: Children (Basel) Date: 2021-03-05